Selux Diagnostics Inc, a provider of a next-generation phenotyping platform, has raised $50 million in Series C financing. RA Capital Management led the round with participation from Sands Capital, Schooner Capital and Northpond Ventures.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: